Overexpression of X-Linked genes in T cells from women with lupus

Journal of Autoimmunity

Volumn 41, Issue , 2013, Pages 60-71

  Hewagama, Anura ^a   Gorelik, Gabriela ^a   Patel, Dipak ^a   Liyanarachchi, Punsisi ^a   Joseph McCune, W ^a   Somers, Emily ^a   Gonzalez Rivera, Tania ^a   The Michigan Lupus Cohort, ^a   Strickland, Faith ^a   Richardson, Bruce ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

Epigenetics; Gene expression; Lupus; MicroRNA; Women's health; X chromosome

Indexed keywords

AZACITIDINE; CD40 LIGAND; CD40LG PROTEIN; CHEMOKINE RECEPTOR CXCR3; DNA METHYLTRANSFERASE; LYMPHOCYTE ANTIGEN; MESSENGER RNA; MICRORNA; OLIGONUCLEOTIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DEMETHYLATION; DISEASE PREDISPOSITION; DNA METHYLATION; FEMALE; GENE OVEREXPRESSION; HUMAN; KLINEFELTER SYNDROME; LUPUS VULGARIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; X CHROMOSOME;

ADULT; AZACITIDINE; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CELLS, CULTURED; DNA METHYLATION; FEMALE; GENES, X-LINKED; HUMANS; IMMUNOBLOTTING; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MICRORNAS; MIDDLE AGED; N-ACETYLGLUCOSAMINYLTRANSFERASES; PROTO-ONCOGENE PROTEINS C-CBL; RECEPTORS, CXCR3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEX FACTORS; TRANSCRIPTOME;

EID: 84875923589     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.12.006     Document Type: Article

References (52)

1. Cooper G.S., Stroehla B.C. The epidemiology of autoimmune diseases. Autoimmun Rev 2003, 2:119-125.
2. Buyon J.P., Petri M.A., Kim M.Y., Kalunian K.C., Grossman J., Hahn B.H., et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005, 142:953-962.
3. Huang J.L., Yao T.C., See L.C. Prevalence of pediatric systemic lupus erythematosus and juvenile chronic arthritis in a Chinese population: a nation-wide prospective population-based study in Taiwan. Clin Exp Rheumatol 2004, 22:776-780.
4. Boddaert J., Huong du L.T., Amoura Z., Wechsler B., Godeau P., Piette J.C. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature. Medicine (Baltimore) 2004, 83:348-359.
5. Lockshin M.D., Buyon J.P. Estrogens and lupus: bubbling cauldron or another overrated Witches' Brew?. Arthritis Rheum 2007, 56:1048-1050.
6. Lockshin M.D. Sex ratio and rheumatic disease: excerpts from an institute of medicine report. Lupus 2002, 11:662-666.
7. Scofield R.H., Bruner G.R., Namjou B., Kimberly R.P., Ramsey-Goldman R., Petri M., et al. Klinefelter's syndrome (47, XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 2008, 58:2511-2517.
8. Cooney C.M., Bruner G.R., Aberle T., Namjou-Khales B., Myers L.K., Feo L., et al. 46, X, del(X)(q13) Turner's syndrome women with systemic lupus erythematosus in a pedigree multiplex for SLE. Genes Immun 2009, 10:478-481.
9. Richardson B. Primer: epigenetics of autoimmunity. Nat Clin Pract Rheumatol 2007, 3:521-527.
10. Cornacchia E., Golbus J., Maybaum J., Strahler J., Hanash S., Richardson B. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity. J Immunol 1988, 140:2197-2200.
11. Basu D., Liu Y., Wu A., Yarlagadda S., Gorelik G.J., Kaplan M.J., et al. Stimulatory and inhibitory killer Ig-like receptor molecules are expressed and functional on lupus T cells. J Immunol 2009, 183:3481-3487.
12. Quddus J., Johnson K.J., Gavalchin J., Amento E.P., Chrisp C.E., Yung R.L., et al. Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 1993, 92:38-53.
13. Javierre B.M., Richardson B. A new epigenetic challenge: systemic lupus erythematosus. Adv Exp Med Biol 2011, 711:117-136.
14. Lu Q., Wu A., Tesmer L., Ray D., Yousif N., Richardson B. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J Immunol 2007, 179:6352-6358.
15. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShane D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25:1271-1277.
16. Sawalha A.H., Wang L., Nadig A., Somers E.C., McCune W.J., Hughes T., et al. Sex-specific differences in the relationship between genetic susceptibility, T cell DNA demethylation and lupus flare severity. J Autoimmun 2012, 38:J216-J222.
17. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 1992, 35:630-640.
18. Hewagama A., Patel D., Yarlagadda S., Strickland F.M., Richardson B.C. Stronger inflammatory/cytotoxic T-cell response in women identified by microarray analysis. Genes Immun 2009, 10:509-516.
19. Gorelik G.J., Yarlagadda S., Richardson B.C. PKCdelta oxidation contributes to erk inactivation in lupus t cells. Arthritis Rheum 2012.
20. Gorelik G., Fang J.Y., Wu A., Sawalha A.H., Richardson B. Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus. J Immunol 2007, 179:5553-5563.
21. Enghard P., Humrich J.Y., Rudolph B., Rosenberger S., Biesen R., Kuhn A., et al. CXCR3+CD4+ T cells are enriched in inflamed kidneys and urine and provide a new biomarker for acute nephritis flares in systemic lupus erythematosus patients. Arthritis Rheum 2009, 60:199-206.
22. Issad T., Masson E., Pagesy P. O-GlcNAc modification, insulin signaling and diabetic complications. Diabetes Metab 2010, 36:423-435.
23. Love D.C., Krause M.W., Hanover J.A. O-GlcNAc cycling: emerging roles in development and epigenetics. Semin Cell Dev Biol 2010, 21:646-654.
24. Golks A., Tran T.T., Goetschy J.F., Guerini D. Requirement for O-linked N-acetylglucosaminyltransferase in lymphocytes activation. EMBO J 2007, 26:4368-4379.
25. Mikkola M.L. Molecular aspects of hypohidrotic ectodermal dysplasia. Am J Med Genet A 2009, 149A:2031-2036.
26. Hodge D.L., Schill W.B., Wang J.M., Blanca I., Reynolds D.A., Ortaldo J.R., et al. IL-2 and IL-12 alter NK cell responsiveness to IFN-gamma-inducible protein 10 by down-regulating CXCR3 expression. J Immunol 2002, 168:6090-6098.
27. Naramura M., Jang I.K., Kole H., Huang F., Haines D., Gu H. c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation. Nat Immunol 2002, 3:1192-1199.
28. Murphy M.A., Schnall R.G., Venter D.J., Barnett L., Bertoncello I., Thien C.B., et al. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice. Mol Cell Biol 1998, 18:4872-4882.
29. Pedraza-Alva G., Merida L.B., del Rio R., Fierro N.A., Cruz-Munoz M.E., Olivares N., et al. CD43 regulates the threshold for T cell activation by targeting Cbl functions. IUBMB Life 2011, 63:940-948.
30. Jury E.C., Kabouridis P.S., Flores-Borja F., Mageed R.A., Isenberg D.A. Altered lipid raft-associated signaling and ganglioside expression in T lymphocytes from patients with systemic lupus erythematosus. J Clin Invest 2004, 113:1176-1187.
31. Lu Q., Wu A., Richardson B.C. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J Immunol 2005, 174:6212-6219.
32. Strickland F.M., Hewagama A., Lu Q., Wu A., Hinderer R., Webb R., et al. Environmental exposure, estrogen and two X chromosomes are required for disease development in an epigenetic model of lupus. J Autoimmun 2012, 38:J135-J143.
33. Pisitkun P., Deane J.A., Difilippantonio M.J., Tarasenko T., Satterthwaite A.B., Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science 2006, 312:1669-1672.
34. Chagnon P., Schneider R., Hebert J., Fortin P.R., Provost S., Belisle C., et al. Identification and characterization of an Xp22.33;Yp11.2 translocation causing a triplication of several genes of the pseudoautosomal region 1 in an XX male patient with severe systemic lupus erythematosus. Arthritis Rheum 2006, 54:1270-1278.
35. Liu Y., Kuick R., Hanash S., Richardson B. DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors. Clin Immunol 2009, 130:213-224.
36. Higuchi T., Aiba Y., Nomura T., Matsuda J., Mochida K., Suzuki M., et al. Cutting edge: ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease. J Immunol 2002, 168:9-12.
37. Peng S.L. Altered T and B lymphocyte signaling pathways in lupus. Autoimmun Rev 2009, 8:179-183.
38. Love D.C., Hanover J.A. The hexosamine signaling pathway: deciphering the "O-GlcNAc code". Sci STKE 2005, 2005:re13.
39. Hart G.W., Housley M.P., Slawson C. Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 2007, 446:1017-1022.
40. Zachara N.E., Hart G.W. Cell signaling, the essential role of O-GlcNAc!. Biochim Biophys Acta 2006, 1761:599-617.
41. Shafi R., Iyer S.P., Ellies L.G., O'Donnell N., Marek K.W., Chui D., et al. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci U S A 2000, 97:5735-5739.
42. O'Donnell N., Zachara N.E., Hart G.W., Marth J.D. Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol Cell Biol 2004, 24:1680-1690.
43. Kearse K.P., Hart G.W. Topology of O-linked N-acetylglucosamine in murine lymphocytes. Arch Biochem Biophys 1991, 290:543-548.
44. Tsokos G.C., Nambiar M.P., Juang Y.T. Activation of the Ets transcription factor Elf-1 requires phosphorylation and glycosylation: defective expression of activated Elf-1 is involved in the decreased TCR zeta chain gene expression in patients with systemic lupus erythematosus. Ann N Y Acad Sci 2003, 987:240-245.
45. Huang J.B., Clark A.J., Petty H.R. The hexosamine biosynthesis pathway negatively regulates IL-2 production by Jurkat T cells. Cell Immunol 2007, 245:1-6.
46. Yao A.Y., Tang H.Y., Wang Y., Feng M.F., Zhou R.L. Inhibition of the activating signals in NK92 cells by recombinant GST-sHLA-G1a chain. Cell Res 2004, 14:155-160.
47. Naramura M., Kole H.K., Hu R.J., Gu H. Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc Natl Acad Sci U S A 1998, 95:15547-15552.
48. Brembilla N.C., Weber J., Rimoldi D., Pradervand S., Schutz F., Pantaleo G., et al. c-Cbl expression levels regulate the functional responses of human central and effector memory CD4 T cells. Blood 2008, 112:652-660.
49. Methi T., Berge T., Torgersen K.M., Tasken K. Reduced Cbl phosphorylation and degradation of the zeta-chain of the T-cell receptor/CD3 complex in T cells with low Lck levels. Eur J Immunol 2008, 38:2557-2563.
50. Wang H.Y., Altman Y., Fang D., Elly C., Dai Y., Shao Y., et al. Cbl promotes ubiquitination of the T cell receptor zeta through an adaptor function of Zap-70. J Biol Chem 2001, 276:26004-26011.
51. Balagopalan L., Barr V.A., Sommers C.L., Barda-Saad M., Goyal A., Isakowitz M.S., et al. c-Cbl-mediated regulation of LAT-nucleated signaling complexes. Mol Cell Biol 2007, 27:8622-8636.
52. Fullwood M.J., Liu M.H., Pan Y.F., Liu J., Xu H., Mohamed Y.B., et al. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 2009, 462:58-64.